Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Aptamers for Medical Applications -

Aptamers for Medical Applications

From Diagnosis to Therapeutics

Yiyang Dong (Herausgeber)

Buch | Softcover
462 Seiten
2022 | 1st ed. 2021
Springer Verlag, Singapore
978-981-334-840-0 (ISBN)
CHF 239,65 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This book outlines comprehensively the main medical uses of aptamers, from diagnosis to therapeutics in fourteen chapters. It is therefore of interest for not only academic researchers, but also practitioners and medical researchers in various fields of medical science, medical research and bio-analytical chemistry.
This book outlines comprehensively the main medical uses of aptamers, from diagnosis to therapeutics in fourteen chapters. Pioneering topics covered include aptamer pharmaceuticals, aptamers for malign tumors, aptamers for personalized therapeutics and aptamers for point-of-care testing. The book offers an essential guide for medical scientists interested in developing aptamer-based schemes for better theranostics. It is therefore of interest for not only academic researchers, but also practitioners and medical researchers in various fields of medical science, medical research and bio-analytical chemistry.  

 Yiyang Dong is Full Professor and Director of Food Safety & Risk Assessment Laboratory of Beijing University of Chemical Technology (BUCT) in Beijing, China. Having obtained his Ph.D. from Peking University in 1998 and completed a postdoctoral position in the University of Tokyo, Japan, in 2011, he then spent most of his career as an expert analytical chemist in Chinese Academy of Inspection and Quarantine before taking up his present appointment at BUCT. He has authored over 100 scientific publications in both analytical and bio-analytical fields using aptamer-based biosensor, capillary electrophoresis, liquid chromatography, microfluidics and mass spectrometry. Among his current interests are the selection of class-specific aptamers, development of various applicable aptasensors, native mass spectrometry for stoichiometric aptamer-ligand research and lateral flow assay for medical diagnosis and food safety analysis.

Introduction of aptamer and SELEX.- Aptamers as molecular probing or medical imaging agents.- Development of aptamer based pharmaceuticals.- Aptamers for drug delivery or controlled release.- Aptamers for point-of-care testing schemes.- Aptamer based medical devices.- Aptamers for personalized therapeutics.- Aptamer for targeted therapy.- Aptamers for the diagnosis of malign tumors.- Aptamers for the diagnosis of cardiovascular diseases.- Aptamers for the diagnosis of infectious diseases.- Aptamers for the diagnosis of autoimmune diseases.- Aptamers for the diagnosis of neurodegenerative disease.- Aptamer focused research frontiers of medical significance (exosomes, native-MS, artificial genetic alphabet, computational prediction, stem-cell, aptamer crystallology, aptamer microarrays etc.).- Perspectives of aptamers for medical applications.

Erscheinungsdatum
Zusatzinfo 115 Illustrations, color; 11 Illustrations, black and white; XIII, 462 p. 126 illus., 115 illus. in color.
Verlagsort Singapore
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizin / Pharmazie Pharmazie
Medizin / Pharmazie Physiotherapie / Ergotherapie Orthopädie
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Biochemie
Naturwissenschaften Chemie Physikalische Chemie
Technik Medizintechnik
Technik Umwelttechnik / Biotechnologie
Schlagworte Aptamer • biochemical engineering • Cardiovascular Diseases • Drug Delivery • Infectious Diseases • Malign Tumors • Personalized Therapeutics Autoimmune Diseases • Point-of-Care testing • SELEX • target therapy
ISBN-10 981-334-840-2 / 9813348402
ISBN-13 978-981-334-840-0 / 9789813348400
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Spiraldynamik - programmierte Therapie für konkrete Resultate

von Christian Larsen

Buch | Hardcover (2021)
Thieme (Verlag)
CHF 146,95